Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Return on Capital Employed (2019 - 2026)

Bicycle Therapeutics (BCYC) has disclosed Return on Capital Employed for 8 consecutive years, with 0.38% as the latest value for Q1 2026.

  • For Q1 2026, Return on Capital Employed fell 9.0% year-over-year to 0.38%; the TTM value through Mar 2026 reached 0.38%, down 9.0%, while the annual FY2025 figure was 0.32%, 2.0% down from the prior year.
  • Return on Capital Employed hit 0.38% in Q1 2026 for Bicycle Therapeutics, down from 0.36% in the prior quarter.
  • Across five years, Return on Capital Employed topped out at 0.18% in Q1 2022 and bottomed at 0.4% in Q3 2025.
  • Average Return on Capital Employed over 5 years is 0.31%, with a median of 0.34% recorded in 2024.
  • Year-over-year, Return on Capital Employed increased 15bps in 2022 and then dropped -20bps in 2025.
  • Bicycle Therapeutics' Return on Capital Employed stood at 0.32% in 2022, then dropped by -7bps to 0.35% in 2023, then soared by 33bps to 0.23% in 2024, then plummeted by -57bps to 0.36% in 2025, then decreased by -5bps to 0.38% in 2026.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.38%, 0.36%, and 0.4% for Q1 2026, Q4 2025, and Q3 2025 respectively.